Perennial Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$453K Sell
18,794
-782
-4% -$20.5K 0.03% 341
2026
Q1
$550K Sell
19,576
-1,261
-6% -$33.6K 0.04% 282
2025
Q4
$519K Buy
20,837
+3,857
+23% +$97.3K 0.04% 277
2025
Q3
$433K Sell
16,980
-5,651
-25% -$139K 0.04% 284
2025
Q2
$549K Sell
22,631
-2,291
-9% -$53.4K 0.05% 251
2025
Q1
$631K Buy
24,922
+2
+0% +$52 0.07% 213
2024
Q4
$661K Buy
24,920
+8,195
+49% +$222K 0.08% 192
2024
Q3
$484K Buy
16,725
+1,176
+8% +$34.3K 0.06% 217
2024
Q2
$435K Buy
15,549
+1,358
+10% +$37.4K 0.06% 215
2024
Q1
$394K Buy
14,191
+2,676
+23% +$74.3K 0.06% 212
2023
Q4
$332K Sell
11,515
-876
-7% -$26.5K 0.05% 230
2023
Q3
$411K Sell
12,391
-745
-6% -$26.3K 0.07% 190
2023
Q2
$482K Sell
13,136
-71
-0.5% -$2.76K 0.08% 181
2023
Q1
$539K Buy
13,207
+220
+2% +$9.5K 0.1% 164
2022
Q4
$665K Buy
12,987
+298
+2% +$14.3K 0.27% 74
2022
Q3
$555K Sell
12,689
-2,439
-16% -$119K 0.25% 78
2022
Q2
$793K Sell
15,128
-52
-0.3% -$2.65K 0.31% 64
2022
Q1
$788K Buy
15,180
+272
+2% +$14.1K 0.25% 81
2021
Q4
$880K Buy
14,908
+1,083
+8% +$53.7K 0.28% 76
2021
Q3
$594K Buy
13,825
+1,081
+8% +$47.9K 0.21% 98
2021
Q2
$499K Buy
12,744
+3,387
+36% +$132K 0.18% 110
2021
Q1
$339K Buy
9,357
+127
+1% +$4.51K 0.13% 130
2020
Q4
$340K Sell
9,230
-2,020
-18% -$74.1K 0.15% 115
2020
Q3
$390K Buy
11,250
+1,831
+19% +$64.2K 0.2% 96
2020
Q2
$292K Buy
+9,419
New +$320K 0.2% 102

Other funds holding PFE

Perennial Investment Advisors's PFE Position: Q2 2026 in Review

Perennial Investment Advisors reduced its Pfizer (PFE) stake by 4% in Q2 2026, selling an estimated $20.5K and leaving 18,794 shares worth $453K. The position accounts for 0.03% of the portfolio, ranked #341.

Perennial Investment Advisors first reported a position in PFE in Q2 2020 and has held it in 25 quarters since. The position peaked at $880K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Perennial Investment Advisors held 18,794 shares of Pfizer worth $453K as of Q2 2026.
  • Perennial Investment Advisors sold 782 Pfizer shares in Q2 2026, an estimated $20.5K.
  • Pfizer made up 0.03% of Perennial Investment Advisors's portfolio in Q2 2026, its #341 holding.
  • Perennial Investment Advisors first reported a position in Pfizer in Q2 2020 and has held it in 25 quarters since.
  • Perennial Investment Advisors's Pfizer position peaked at $880K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Perennial Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.